A clamping device for reducing blood flow in a human limb comprises a first rigid part having a first inner profile, and a second rigid part having a second inner profile generally facing the first inner profile. A coupling portion couples the first rigid part and second rigid part to each other. The first inner profile extends further away from the coupling portion than the second inner profile. The first and second inner profiles define a recess, the recess being shaped to enable the clamping device to be positioned on the human limb, and the clamping device being configured to shift between an expanded configuration and a clamped configuration. The first and second inner profiles are arranged to apply pressure against the human limb when the device is in the clamped configuration and thereby to apply pressure to blood vessels in the human limb and reduce blood flow through the blood vessels.

A headset includes a housing defining an audio cavity, a speaker located within the audio cavity, and first and second sensor modules within the housing in spaced-apart, angled relationship to each other. The housing includes an aperture through which sound from the speaker can pass, and the first and second sensor modules are on opposing sides of a direction from the speaker to the aperture. The first sensor module is configured to direct electromagnetic radiation at a first target region of an ear of a person wearing the headset and to detect a first energy response signal therefrom that is associated with one or more physiological metrics of the subject, and the second sensor module is configured to direct electromagnetic radiation at a second target region of the ear and to detect a second energy response signal therefrom that is associated with the one or more physiological metrics.

Embodiments include a system for determining cardiovascular information for a patient which may include at least one computer system configured to receive patient-specific data regarding a geometry of an anatomical structure of a patient; create a model representing at least a portion of the anatomical structure; create a physics-based model relating to a blood flow characteristic within the anatomical structure; determine a first blood flow rate at at least one point of interest in the model; modify the model; determine a second blood flow rate at a point in the modified model corresponding to the at least one point of interest in the model; and determine a fractional flow reserve value as a ratio of the second blood flow rate to the first blood flow rate.

Embodiments include a system for determining cardiovascular information for a patient which may include at least one computer system configured to receive patient-specific data regarding a geometry of an anatomical structure of a patient; create a model representing at least a portion of the anatomical structure; create a physics-based model relating to a blood flow characteristic within the anatomical structure; determine a first blood flow rate at at least one point of interest in the model; modify the model; determine a second blood flow rate at a point in the modified model corresponding to the at least one point of interest in the model; and determine a fractional flow reserve value as a ratio of the second blood flow rate to the first blood flow rate.

An intravascular sensor device can be used to guide treatment of a diseased blood vessel in the body of a patient. In some examples, the intravascular sensor device includes a pressure sensor and an ultrasound transducer. The intravascular sensor device is used to measure a pressure within the diseased blood vessel and acquire an ultrasound image of the diseased blood vessel. The pressure may be measured during hyperemic blood flow that is caused by a pharmacologic vasodilator drug. The measured pressure can be used to calculate a fractional flow reserve value. The ultrasound image can be used to determine a physical dimension of the blood vessel, such as cross-sectional area. The fractional flow reserve value and physical dimensions of the blood vessel can be used to optimize patient treatment.

Systems and methods are provided that integrate control electronics with a wireless on-board module so that a conformal ultrasound device is a fully functional and self-contained system. Such systems employ integrated control electronics, deep tissue monitoring, wireless communications, and smart machine learning algorithms to analyze data. In particular, a stretchable ultrasonic patch is provided that performs the noted functions. The decoded motion signals may have implications on blood pressure estimation, chronic obstructive pulmonary disease (COPD) diagnosis, heart function evaluation, and many other medical monitoring aspects.

Systems and methods are provided that integrate control electronics with a wireless on-board module so that a conformal ultrasound device is a fully functional and self-contained system. Such systems employ integrated control electronics, deep tissue monitoring, wireless communications, and smart machine learning algorithms to analyze data. In particular, a stretchable ultrasonic patch is provided that performs the noted functions. The decoded motion signals may have implications on blood pressure estimation, chronic obstructive pulmonary disease (COPD) diagnosis, heart function evaluation, and many other medical monitoring aspects.

A monitoring system includes a wearable patch device configured to be secured to a body of a patient, the wearable patch device comprising a patch body, a first discrete transducer associated with a first position of the patch body, a second discrete transducer associated with a second portion of the patch body, and a wireless transmitter, and electronics including one or more processors and one or more memory devices and configured to receive signals based on transducer readings of the first and second discrete transducers and determine an amount of blood flow through one or more valves of a heart of the patient based on the signals.

A monitoring system includes a wearable patch device configured to be secured to a body of a patient, the wearable patch device comprising a patch body, a first discrete transducer associated with a first position of the patch body, a second discrete transducer associated with a second portion of the patch body, and a wireless transmitter, and electronics including one or more processors and one or more memory devices and configured to receive signals based on transducer readings of the first and second discrete transducers and determine an amount of blood flow through one or more valves of a heart of the patient based on the signals.

The present invention relates to the use of contrast-enhanced ultrasound using microbubble-based ultrasound contrast agents to accomplish noninvasive subharmonic aided pressure estimation (SHAPE) in a region of interest (ROI) of a subject. The method of the invention provides a non-invasive, direct, and accurate method for pressure estimation.